19 results
424B5
NSPR
InspireMD Inc
31 May 24
Prospectus supplement for primary offering
4:49pm
for the purpose of expanding our presence in the Asian markets. In January 2024, we received CE mark recertification under the EU’s Medical Device Regulation … regulatory framework. Currently, we are seeking strategic partners for a potential launch of CGuard EPS in Japan and other Asian countries.
On September
424B3
gmy 0lqimp7e2
2 Jun 23
Prospectus supplement
4:15pm
8-K
EX-99.1
cf8ckmhxm9h91uxy
10 Aug 21
InspireMD Announces Strong Second Quarter 2021 Financial Results
4:10pm
- Prev
- 1
- Next